LYNN WOLFF: Open Payments
NPI 1013231398 · PAOLI, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,243 in 89 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,078 · 2025 $2,243
Food & beverage: $1,966Education: $277
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $561 |
| Actelion Pharmaceuticals US, Inc. | 6 | $244 |
| GlaxoSmithKline, LLC. | 11 | $235 |
| Regeneron Healthcare Solutions, Inc. | 7 | $183 |
| Viatris Specialty LLC | 7 | $169 |
| HARMONY BIOSCIENCES LLC | 4 | $148 |
| Electromed, Inc. | 6 | $104 |
| Verona Pharma, Inc. | 3 | $91 |
| Grifols USA, LLC | 3 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $81 |
Products named: FASENRA, OPSUMIT, DUPIXENT, TRELEGY ELLIPTA, YUPELRI, SMARTVEST, Ohtuvayre, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
